ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

NCT06716021 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

750

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Placebo
DRUG: Etripamil

Sponsor

Milestone Pharmaceuticals Inc.